Derivative exercise or conversion — not an open-market buy.
Traded Nov 14, 2025 · Filed Nov 17, 2025
The boss of TransDigm Group spent $74K of their very own money to buy TransDigm Group shares. Their pile of TransDigm Group shares grew by 9%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$73,556
Shares × reported transaction price
$25K–$100K
+9.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
2 days after results of Nov 12, 2025, 81 days before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,340.60 on Nov 14, 2025, 9% above its 52-week low and 17% below its high, after a 4% rise over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 28% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,288.83 on Oct 3, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.1% | +2.3% | -2.1% |
| 30 days | -6.5% | +2.5% | -9.0% |
| 90 days | -3.6% | +3.5% | -7.1% |
| 180 days | -12.5% | +11.9% | -24.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
TransDigm Group's Co-Chief Operating Officer sold $103K of TransDigm Group shares. Nobody planned it ahead of time.
TransDigm Group's Co-Chief Operating Officer sold $359K of TransDigm Group shares. Nobody planned it ahead of time.